The Remote Opioid Monitoring Act of 2025 directs the Comptroller General to study how remote monitoring affects people who take prescription opioids. Within 18 months of the bill's enactment, the Comptroller General must submit a report to Congress that examines whether remote monitoring improves patient outcomes, reduces costs, and is more effective than standard care without monitoring. The report will also assess how widely remote monitoring is currently used in the United States and other countries, and will provide recommendations on how to expand access to remote monitoring through federal health care programs like Medicare and Medicaid. The study aims to identify which groups of opioid patients could benefit most from this type of monitoring. While the bill itself doesn't authorize specific funding amounts, it represents Congress's effort to gather evidence on whether technology-based monitoring could help address the opioid crisis and improve treatment outcomes.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.